Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis

J Bone Miner Res. 2006 Mar;21(3):354-65. doi: 10.1359/JBMR.051023. Epub 2005 Nov 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use*
  • Humans
  • Osteoporosis / drug therapy*
  • Teriparatide / administration & dosage
  • Teriparatide / adverse effects
  • Teriparatide / therapeutic use*

Substances

  • Bone Density Conservation Agents
  • Teriparatide